| [1] | Ferguson JE 3rd, Kelley RW, Patterson C (2005) Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arterioscler Thromb Vasc Biol 25: 2246–2254. doi: 10.1161/01.atv.0000183609.55154.44
|
| [2] | Drake CJ, Fleming PA (2000) Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95: 1671–1679.
|
| [3] | Downs KM (1998) The murine allantois. Curr Top Dev Biol 39: 1–33.
|
| [4] | Conway SJ, Kruzynska-Frejtag A, Kneer PL, Machnicki M, Koushik SV (2003) What cardiovascular defect does my prenatal mouse mutant have, and why? Genesis 35: 1–21. doi: 10.1002/gene.10152
|
| [5] | Kam EP, Gardner L, Loke YW, King A (1999) The role of trophoblast in the physiological change in decidual spiral arteries. Hum Reprod 14: 2131–2138. doi: 10.1093/humrep/14.8.2131
|
| [6] | Myatt L, Webster RP (2009) Vascular biology of preeclampsia. J Thromb Haemost 7: 375–384. doi: 10.1111/j.1538-7836.2008.03259.x
|
| [7] | James JL, Stone PR, Chamley LW (2005) Cytotrophoblast differentiation in the first trimester of pregnancy: evidence for separate progenitors of extravillous trophoblasts and syncytiotrophoblast. Reproduction 130: 95–103. doi: 10.1530/rep.1.00723
|
| [8] | Mayhew TM (2001) Villous trophoblast of human placenta: a coherent view of its turnover, repair and contributions to villous development and maturation. Histol Histopathol 16: 1213–1224.
|
| [9] | Fisher SJ, Damsky CH (1993) Human cytotrophoblast invasion. Semin Cell Biol 4: 183–188. doi: 10.1006/scel.1993.1022
|
| [10] | Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, et al. (2002) Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 250: 358–373. doi: 10.1006/dbio.2002.0773
|
| [11] | Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, et al. (2004) Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 114: 744–754. doi: 10.1172/jci200422991
|
| [12] | Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649–658. doi: 10.1172/jci200317189
|
| [13] | Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, et al. (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200–1204. doi: 10.1016/0002-9378(89)90665-0
|
| [14] | Fisher SJ (2004) The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2: 53.
|
| [15] | Ferguson JE 3rd, Wu Y, Smith K, Charles P, Powers K, et al. (2007) ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism. Mol Cell Biol 27: 6407–6419. doi: 10.1128/mcb.00511-07
|
| [16] | Bode M, Wu Y, Pi X, Lockyer P, Dechyapirom W, et al. (2011) Regulation of ankyrin repeat and suppressor of cytokine signalling box protein 4 expression in the immortalized murine endothelial cell lines MS1 and SVR: a role for tumour necrosis factor alpha and oxygen. Cell Biochem Funct 29: 334–341. doi: 10.1002/cbf.1755
|
| [17] | Kile BT, Viney EM, Willson TA, Brodnicki TC, Cancilla MR, et al. (2000) Cloning and characterization of the genes encoding the ankyrin repeat and SOCS box-containing proteins Asb-1, Asb-2, Asb-3 and Asb-4. Gene 258: 31–41. doi: 10.1016/s0378-1119(00)00402-9
|
| [18] | Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY (2004) The ankyrin repeat as molecular architecture for protein recognition. Protein Sci 13: 1435–1448. doi: 10.1110/ps.03554604
|
| [19] | Kohroki J, Nishiyama T, Nakamura T, Masuho Y (2005) ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. FEBS Lett 579: 6796–6802. doi: 10.1016/j.febslet.2005.11.016
|
| [20] | Li JY, Chai B, Zhang W, Wu X, Zhang C, et al. (2011) Ankyrin repeat and SOCS box containing protein 4 (Asb-4) colocalizes with insulin receptor substrate 4 (IRS4) in the hypothalamic neurons and mediates IRS4 degradation. BMC Neurosci 12: 95. doi: 10.1186/1471-2202-12-95
|
| [21] | Li JY, Chai BX, Zhang W, Wang H, Mulholland MW (2010) Expression of ankyrin repeat and suppressor of cytokine signaling box protein 4 (Asb-4) in proopiomelanocortin neurons of the arcuate nucleus of mice produces a hyperphagic, lean phenotype. Endocrinology 151: 134–142. doi: 10.1210/en.2009-0560
|
| [22] | Kim SK, Rhim SY, Lee MR, Kim JS, Kim HJ, et al. (2008) Stage-specific expression of ankyrin and SOCS box protein-4 (Asb-4) during spermatogenesis. Mol Cells 25: 317–321.
|
| [23] | De Val S (2011) Key transcriptional regulators of early vascular development. Arterioscler Thromb Vasc Biol 31: 1469–1475. doi: 10.1161/atvbaha.110.221168
|
| [24] | Luttun A, Carmeliet P (2003) De novo vasculogenesis in the heart. Cardiovasc Res 58: 378–389. doi: 10.1016/s0008-6363(03)00258-x
|
| [25] | Janatpour MJ, McMaster MT, Genbacev O, Zhou Y, Dong J, et al. (2000) Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration. Development 127: 549–558.
|
| [26] | Lasorella A, Rothschild G, Yokota Y, Russell RG, Iavarone A (2005) Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol Cell Biol 25: 3563–3574. doi: 10.1128/mcb.25.9.3563-3574.2005
|
| [27] | Liu YP, Burleigh D, Durning M, Hudson L, Chiu IM, et al. (2004) Id2 is a primary partner for the E2–2 basic helix-loop-helix transcription factor in the human placenta. Mol Cell Endocrinol 222: 83–91. doi: 10.1016/j.mce.2004.04.016
|
| [28] | Coma S, Amin DN, Shimizu A, Lasorella A, Iavarone A, et al. (2010) Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F. Cancer Res 70: 3823–3832. doi: 10.1158/0008-5472.can-09-3048
|
| [29] | Wong MV, Palasingam P, Kolatkar PR (2012) Cloning, purification and preliminary X-ray data analysis of the human ID2 homodimer. Acta Crystallogr Sect F Struct Biol Cryst Commun 68: 1354–1358. doi: 10.1107/s174430911203895x
|
| [30] | Zebedee Z, Hara E (2001) Id proteins in cell cycle control and cellular senescence. Oncogene 20: 8317–8325. doi: 10.1038/sj.onc.1205092
|
| [31] | Ferguson JE (2007) Investigating the Role of Ankyrin Repeat and SOCS Box Protein 4 (ASB4) During Vascular Development: The University of North Carolina at Chapel Hill.
|
| [32] | Dokras A, Hoffmann DS, Eastvold JS, Kienzle MF, Gruman LM, et al. (2006) Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia. Biol Reprod 75: 899–907. doi: 10.1095/biolreprod.106.053603
|
| [33] | Waldo KL, Kumiski D, Kirby ML (1996) Cardiac neural crest is essential for the persistence rather than the formation of an arch artery. Dev Dyn 205: 281–292. doi: 10.1002/(sici)1097-0177(199603)205:3<281::aid-aja8>3.3.co;2-1
|
| [34] | Wolfe M (2006) Culture and Transfection of Human Choriocarcinoma Cells. In: Soares M, Hunt J, editors. Placenta and Trophoblast: Humana Press. 229–239.
|
| [35] | Himeno E, Tanaka S, Kunath T (2008) Isolation and manipulation of mouse trophoblast stem cells. Curr Protoc Stem Cell Biol Chapter 1: Unit 1E 4.
|
| [36] | Hohn HP, Linke M, Ugele B, Denker HW (1998) Differentiation markers and invasiveness: discordant regulation in normal trophoblast and choriocarcinoma cells. Exp Cell Res 244: 249–258. doi: 10.1006/excr.1998.4184
|
| [37] | Chen Q, Stone PR, McCowan LM, Chamley LW (2005) Interaction of Jar choriocarcinoma cells with endothelial cell monolayers. Placenta 26: 617–625. doi: 10.1016/j.placenta.2004.09.014
|
| [38] | Aldo PB, Krikun G, Visintin I, Lockwood C, Romero R, et al. (2007) A novel three-dimensional in vitro system to study trophoblast-endothelium cell interactions. Am J Reprod Immunol 58: 98–110. doi: 10.1111/j.1600-0897.2007.00493.x
|
| [39] | Muntener M, Hsu YC (1977) Development of trophoblast and placenta of the mouse. A reinvestigation with regard to the in vitro culture of mouse trophoblast and placenta. Acta Anat (Basel) 98: 241–252. doi: 10.1159/000144801
|
| [40] | Uy GD, Downs KM, Gardner RL (2002) Inhibition of trophoblast stem cell potential in chorionic ectoderm coincides with occlusion of the ectoplacental cavity in the mouse. Development 129: 3913–3924.
|
| [41] | Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, et al. (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99: 2139–2151. doi: 10.1172/jci119387
|
| [42] | Damsky CH, Fitzgerald ML, Fisher SJ (1992) Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 89: 210–222. doi: 10.1172/jci115565
|
| [43] | Horie K, Fujita J, Takakura K, Kanzaki H, Kaneko Y, et al. (1992) Expression of c-kit protein during placental development. Biol Reprod 47: 614–620. doi: 10.1095/biolreprod47.4.614
|
| [44] | Mitsunari M, Harada T, Tanikawa M, Iwabe T, Taniguchi F, et al. (1999) The potential role of stem cell factor and its receptor c-kit in the mouse blastocyst implantation. Mol Hum Reprod 5: 874–879. doi: 10.1093/molehr/5.9.874
|
| [45] | Merviel P, Challier JC, Carbillon L, Foidart JM, Uzan S (2001) The role of integrins in human embryo implantation. Fetal Diagn Ther 16: 364–371. doi: 10.1159/000053942
|
| [46] | Vatansever HS, Inan VS, Lacin S, Koyuncu F (2003) Immunolocalization of alphaV, alpha3 and beta1 integrins in the human placenta with pre-eclampsia. Acta Histochem 105: 253–260. doi: 10.1078/0065-1281-00708
|
| [47] | Fajerman I, Schwartz AL, Ciechanover A (2004) Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. Biochem Biophys Res Commun 314: 505–512. doi: 10.1016/j.bbrc.2003.12.116
|
| [48] | Walter-Yohrling J, Morgenbesser S, Rouleau C, Bagley R, Callahan M, et al. (2004) Murine endothelial cell lines as models of tumor endothelial cells. Clin Cancer Res 10: 2179–2189. doi: 10.1158/1078-0432.ccr-03-1013
|
| [49] | Moser M, Binder O, Wu Y, Aitsebaomo J, Ren R, et al. (2003) BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol Cell Biol 23: 5664–5679. doi: 10.1128/mcb.23.16.5664-5679.2003
|
| [50] | Rossant J, Cross JC (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2: 538–548. doi: 10.1038/35080570
|
| [51] | Li JY, Chai BX, Zhang W, Liu YQ, Ammori JB, et al. (2007) Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity. Cell Signal 19: 1185–1192. doi: 10.1016/j.cellsig.2006.12.010
|
| [52] | Mizuno Y, Sotomaru Y, Katsuzawa Y, Kono T, Meguro M, et al. (2002) Asb4, Ata3, and Dcn are novel imprinted genes identified by high-throughput screening using RIKEN cDNA microarray. Biochem Biophys Res Commun 290: 1499–1505. doi: 10.1006/bbrc.2002.6370
|
| [53] | Norton JD (2000) ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113 (Pt 22): 3897–3905. doi: 10.1016/s0962-8924(97)01183-5
|
| [54] | Lasorella A, Uo T, Iavarone A (2001) Id proteins at the cross-road of development and cancer. Oncogene 20: 8326–8333. doi: 10.1038/sj.onc.1205093
|
| [55] | Niola F, Zhao X, Singh D, Castano A, Sullivan R, et al. (2012) Id proteins synchronize stemness and anchorage to the niche of neural stem cells. Nat Cell Biol 14: 477–487. doi: 10.1038/ncb2490
|
| [56] | Langlands K, Yin X, Anand G, Prochownik EV (1997) Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. J Biol Chem 272: 19785–19793. doi: 10.1074/jbc.272.32.19785
|
| [57] | Carmeliet P (1999) Developmental biology. Controlling the cellular brakes. Nature 401: 657–658. doi: 10.1038/44304
|
| [58] | Miyazono K, Miyazawa K (2002) Id: a target of BMP signaling. Sci STKE 2002: pe40. doi: 10.1126/stke.2002.151.pe40
|
| [59] | Samanta J, Kessler JA (2004) Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131: 4131–4142. doi: 10.1242/dev.01273
|
| [60] | Bounpheng MA, Dimas JJ, Dodds SG, Christy BA (1999) Degradation of Id proteins by the ubiquitin-proteasome pathway. FASEB J 13: 2257–2264.
|
| [61] | Lasorella A, Stegmuller J, Guardavaccaro D, Liu G, Carro MS, et al. (2006) Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature 442: 471–474. doi: 10.1038/nature04895
|
| [62] | Benezra R, Rafii S, Lyden D (2001) The Id proteins and angiogenesis. Oncogene 20: 8334–8341. doi: 10.1038/sj.onc.1205160
|
| [63] | Mutter WP, Karumanchi SA (2008) Molecular mechanisms of preeclampsia. Microvasc Res 75: 1–8. doi: 10.1016/j.mvr.2007.04.009
|
